Back to search

National and Kapodistrian University of Athens

Κλινική εξέλιξη στο σύνδρομο αντιφωσφολιπιδίων

Abstract

dc:description

Antiphospholipid syndrome (APS) is an immune-mediated acquired thrombophilia characterized by recurrent venous and/or arterial thrombosis and/or pregnancy morbidity as well as the presence of antiphospholipid antibodies detected as anticardiolipin antibodies, antibodies to ß2-glycoprotein I or lupus anticoagulant. Clinical manifestations of APS are associated with the size and site of the occluded vessels.The objectives of this thesis are:• The description of morbidity, mortality and organ damage in APS • The use of positron emission tomography (PET) and magnetic resonance imaging (MRI) for the detection of ischemic brain lesions in patients with APS.For these purposes we conducted two studiesIn the first study we analysed 135 patients, clustered according to initial event: arterial thrombosis including stroke (AT; n = 46), venous thrombosis including pulmonary emboli (VT; n = 53), or pregnancy morbidity (PM; n = 36). Disease progression according to initial event and prevalence of organ damage was observed. Our analysis showed that APS occurs among young individuals (mean age 33.3 ± 11.9 yrs). One-third of the patients have APS secondary to systemic lupus erythematosus (SLE) or SLE-like disease. A broad spectrum of clinical manifestations marks the disease onset even before diagnosis. The pattern of initial presentation is preserved with regard to second event; VT is followed by VT (84%), AT is followed by AT (95%), and PM is followed by PM (88.9%). The highest morbidity is attributed to neurologic damage. PM is more likely to be followed by a second event, yet is associated with less organ damage than AT and VT. After a mean followup of 7.55 years, 29% of patients experienced organ damage and 5 died, with Systemic Lupus International Collaborating Clinics score associated with increased mortality (HR 1.31, 95% CI 1.07–1.60, p = 0.01, per 1-unit increase); haematological malignancies occurred in 2 patients after a cumulative followup of 1020 person-years. Coexistent SLE adds significant damage in patients with APS. In conclusion, APS is a disease of young individuals, who experience increased morbidity. Neurologic damage is the most common cause of morbidity. AT at presentation as well as coexistent SLE are associated with poor outcome.In the second study we investigated the detection of brain ischemia with PET and MRI. Nine patients with APS, four exhibiting neurological symptoms and five employed as control underwent MRI and PET. The acquired images were independently and blindly interpreted by two reviewers. For the patients that exhibited neurological symptoms the MRI confirmed the presence of ischemic brain lesions, which were not detected by the PET. The control patients had no pathological findings in both imaging techniques. This pilot study suggests that PET is inferior to MRI in detecting brain infarction in patients with APS.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Grika, Eleftheria
  • Γρίκα, Ελευθερία

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/38502

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Grika, Eleftheria; Γρίκα, Ελευθερία. Κλινική εξέλιξη στο σύνδρομο αντιφωσφολιπιδίων. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/38502